Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01916616 · ClinicalTrials.gov registry record · NA
A Multidisciplinary Approach to Vocal Cord Dysfunction: A Novel Pilot Study
A NA study of Vocal Cord Dysfunction, sponsored by CAMC Health System.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01916616: Completed NA study of Vocal Cord Dysfunction, sponsored by CAMC Health System.
NCT01916616 is a NA study of Vocal Cord Dysfunction that has completed, run by CAMC Health System. The registered enrollment target is 20 participants, below the 62-participant average among 3 other Vocal Cord Dysfunction trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01916616, a NA study of Vocal Cord Dysfunction, has completed, sponsored by CAMC Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Vocal Cord Dysfunction (VCD) is characterized by involuntary closure of the vocal cords while inhaling. Children and adolescents with VCD may experience multiple symptoms, including difficulty breathing, coughing, wheezing, neck tightness, and voice changes. There is limited information on optimal management of VCD. In our proposed study, we will use cognitive-behavioral therapy (CBT) techniques to change how patients respond to their VCD symptoms. Measurements of airflow during breathing as well as symptom frequency and intensity will be examined prior to and following a series of four therapy sessions with a clinical psychologist that are focused on teaching patients strategies to decrease symptom reactivity.
Primary Outcome
Self-reported number of symptomatic episodes and mean intensity of episodes pre and post-CBT intervention will be compared. Symptom intensity will be measured using an 11 point Likert Scale for self-reported distress for each recorded VCD episode.
Conditions Studied
Interventions
- BEHAVIORAL Four therapy sessions with a psychologist utilizing cognitive-behavioral therapy techniques
Study Locations (1)
West Virginia
- Department of Pediatric, West Virginia University-Charleston Division - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-09-01 |
| Est. Completion | 2015-06-30 |
| Phase | NA |
What the finished NCT01916616 record still lists
NCT01916616 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 62-participant average among 3 other Vocal Cord Dysfunction trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Vocal Cord Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Four therapy sessions with a psychologist utilizing cognitive-behavioral therapy techniques is the first listed.
NCT01916616 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT01916616 about?
NCT01916616 is a clinical study titled "A Multidisciplinary Approach to Vocal Cord Dysfunction: A Novel Pilot Study". Vocal Cord Dysfunction (VCD) is characterized by involuntary closure of the vocal cords while inhaling. Children and adolescents with VCD may experience multiple symptoms, including difficulty breathing, coughing, wheezing, neck tightness, and voice changes. There is limited information on optimal m...
What is the current status of trial NCT01916616?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-09-01. Estimated completion is 2015-06-30.
What conditions does trial NCT01916616 study?
This clinical trial studies the following conditions: Vocal Cord Dysfunction.
What interventions are being tested in trial NCT01916616?
The interventions under investigation include: Four therapy sessions with a psychologist utilizing cognitive-behavioral therapy techniques (BEHAVIORAL).
Who is sponsoring clinical trial NCT01916616?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01916616 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vocal Cord Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Paradoxical Vocal Fold Motion Disorder (PVFMD) With a Form of Respiratory Retraining Technique
COMPLETED · NA
-
Detection of Vocal Fold Motion Impairment on Noninvasive Positive Pressure
RECRUITING
-
Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Motion
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI